171 related articles for article (PubMed ID: 24269703)
1. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
[TBL] [Abstract][Full Text] [Related]
2. Increased Th17 and Treg levels in peripheral blood positively correlate with minimal residual disease in acute myeloid leukaemia.
Wang Z; Liu T; Li Y; Li Z; Bi K
Hematology; 2024 Dec; 29(1):2346971. PubMed ID: 38682816
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemia.
Wu H; Li P; Shao N; Ma J; Ji M; Sun X; Ma D; Ji C
Oncol Lett; 2012 May; 3(5):1119-1123. PubMed ID: 22783403
[TBL] [Abstract][Full Text] [Related]
4. Single-cell sequencing unveils T-cell characteristic in acute myeloid leukemia.
Zhu G; Lang W; Fu W; Xu L; Cai J; Zhong H
Int Immunopharmacol; 2024 May; 132():111927. PubMed ID: 38555820
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Immune Response Markers in Jorge Lobo's Disease Lesions Suggests the Occurrence of Mixed T Helper Responses with the Dominance of Regulatory T Cell Activity.
Azevedo Mde C; Rosa PS; Soares CT; Fachin LR; Baptista IM; Woods WJ; Garlet GP; Trombone AP; Belone Ade F
PLoS One; 2015; 10(12):e0145814. PubMed ID: 26700881
[TBL] [Abstract][Full Text] [Related]
6. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia.
Huang S; Zhao Y; Lai W; Tan J; Zheng X; Zha X; Li Y; Chen S
Cancer Biol Ther; 2023 Dec; 24(1):2278229. PubMed ID: 37962843
[TBL] [Abstract][Full Text] [Related]
7. After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia.
Delia M; Carluccio P; Mestice A; Frappampina R; Albano F; Specchia G; Musto P
J Immunol Res; 2020; 2020():2134647. PubMed ID: 33204734
[TBL] [Abstract][Full Text] [Related]
8. Lactate acid promotes PD-1
Zhang Y; Huang Y; Hong Y; Lin Z; Zha J; Zhu Y; Li Z; Wang C; Fang Z; Zhou Z; Peng Y; Yu X; Liu L; Xu B
Int Immunopharmacol; 2024 Mar; 130():111765. PubMed ID: 38447414
[TBL] [Abstract][Full Text] [Related]
9. Higher TIGIT+ γδ T
Hou Q; Wang P; Kong X; Chen J; Yao C; Luo X; Li Y; Jin Z; Wu X
Front Immunol; 2024; 15():1321126. PubMed ID: 38711501
[TBL] [Abstract][Full Text] [Related]
10. Elevated profiles of peripheral Th22, Th17, Th2 cells, and decreased percentage of Th1 cells in breast cancer patients.
Peng Z; Dong X; He M; Zhao Y; Liu Y; Li M; Li G; Wang X; Li L; Hu Y
Thorac Cancer; 2023 Nov; 14(33):3282-3294. PubMed ID: 37732365
[TBL] [Abstract][Full Text] [Related]
11. Immune characteristics and prognostic implications of mucosal-associated invariant T cells in acute myeloid leukemia.
Peng Q; Huang R; Wang H; Xiao H; Wang Y; Zhai Z; Wang Z
Cancer Immunol Immunother; 2023 Dec; 72(12):4399-4414. PubMed ID: 37932426
[TBL] [Abstract][Full Text] [Related]
12. Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy.
Hu R; Ling X; Yang T; Zhang J; Gu X; Li F; Chen H; Wen Y; Li Z; Zou Y; Du Y
Clin Exp Med; 2023 Dec; 23(8):4623-4632. PubMed ID: 37925379
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the frequencies of bone marrow lymphocyte subsets in adult acute myeloid leukemia at diagnosis.
Sun K; Wang J; Wang YZ; Shi ZY; Chang Y; Yuan XY; Liu YR; Jiang H; Jiang Q; Huang XJ; Qin YZ
Int J Lab Hematol; 2024 Apr; 46(2):294-302. PubMed ID: 38069563
[TBL] [Abstract][Full Text] [Related]
14. Reduced levels of recent thymic emigrants in acute myeloid leukemia patients.
Li Y; Yin Q; Yang L; Chen S; Geng S; Wu X; Zhong L; Schmidt CA; Przybylski GK
Cancer Immunol Immunother; 2009 Jul; 58(7):1047-55. PubMed ID: 19018534
[TBL] [Abstract][Full Text] [Related]
15. Lytic activity against primary AML cells is stimulated in vitro by an autologous whole cell vaccine expressing IL-2 and CD80.
Hardwick N; Chan L; Ingram W; Mufti G; Farzaneh F
Cancer Immunol Immunother; 2010 Mar; 59(3):379-88. PubMed ID: 19711075
[TBL] [Abstract][Full Text] [Related]
16. The cytokine network in acute myeloid leukemia.
Luciano M; Krenn PW; Horejs-Hoeck J
Front Immunol; 2022; 13():1000996. PubMed ID: 36248849
[TBL] [Abstract][Full Text] [Related]
17. IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report.
Stevens AM; Horton TM; Glasser CL; Gerbing RB; Aplenc R; Alonzo TA; Redell MS
Pediatr Hematol Oncol; 2023 Mar; 40(2):147-158. PubMed ID: 35838057
[TBL] [Abstract][Full Text] [Related]
18. Signals controlling rest and reactivation of T helper memory lymphocytes in bone marrow.
Tokoyoda K; Radbruch A
Cell Mol Life Sci; 2012 May; 69(10):1609-13. PubMed ID: 22460581
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers involved in evaluation of platelets function in South-Eastern Romanian patients with hematological malignancies subtypes.
Matei E; Aschie M; Mitroi AF; Ghinea MM; Gheorghe E; Petcu L; Dobrin N; Chisoi A; Mihaela M
Medicine (Baltimore); 2021 May; 100(20):e25944. PubMed ID: 34011073
[TBL] [Abstract][Full Text] [Related]
20. Effect of changes in lymphocyte subsets at diagnosis in acute myeloid leukemia on prognosis: association with complete remission rates and relapse free survivals.
Park SH; Bae MH; Park CJ; Cho YU; Jang S; Lee JH; Lee KH
J Hematop; 2023 Jun; 16(2):73-84. PubMed ID: 38175440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
